On July 27, Legendary Biotech, a US stock listed company, announced that Huang Ying has stepped down as CEO and director with effect from July 24, 2026. He will remain in office as an advisor until August to ensure a smooth handover. Additionally, the company's board of directors has appointed Alan Bash, the current president of CarvyKTI, as interim CEO. The Board of Directors has also initiated a comprehensive selection process to determine an official successor.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.